Regulus Therapeutics Inc.
Hedge Funds Holdings
Last updated:
Regulus Therapeutics Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 35.5% of the total amount of its stocks outstanding. This makes up a total of 5.41M shares of Regulus Therapeutics Inc.. Compared to the previous quarter, the number fell by -33.26% or -2.69M shares fewer. As for the holding position changes, 21.43% (3) of current hedge fund investors increased the number of shares held, 21.43% (3) of current holders sold a part of the shares held, and 21.43% (3) closed the holdings completely. 3 hedge funds are new holders of Regulus Therapeutics Inc. stock in Q1 2023, it is 21.43% of total holders.
Hedge funds holding Regulus Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 44 |
|---|---|
| Q3 2018 | 30 |
| Q4 2018 | 20 |
| Q1 2019 | 23 |
| Q2 2019 | 20 |
| Q3 2019 | 21 |
| Q4 2019 | 18 |
| Q1 2020 | 22 |
| Q2 2020 | 29 |
| Q3 2020 | 22 |
| Q4 2020 | 28 |
| Q1 2021 | 42 |
| Q2 2021 | 43 |
| Q3 2021 | 39 |
| Q4 2021 | 36 |
| Q1 2022 | 36 |
| Q2 2022 | 26 |
| Q3 2022 | 21 |
| Q4 2022 | 23 |
| Q1 2023 | 14 |
Hedge funds changes in Regulus Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 6 | 6 | 11 | 9 | 12 |
|---|---|---|---|---|---|
| Q3 2018 | 5 | 4 | 10 | 19 | -8 |
| Q4 2018 | 19 | 1 | 0 | 28 | -28 |
| Q1 2019 | 8 | 4 | 4 | 5 | 2 |
| Q2 2019 | 6 | 5 | 5 | 8 | -4 |
| Q3 2019 | 6 | 3 | 3 | 6 | 3 |
| Q4 2019 | 1 | 2 | 4 | 4 | 7 |
| Q1 2020 | 5 | 4 | 5 | 1 | 7 |
| Q2 2020 | 12 | 3 | 5 | 5 | 4 |
| Q3 2020 | 2 | 8 | 4 | 9 | -1 |
| Q4 2020 | 12 | 7 | 3 | 7 | -1 |
| Q1 2021 | 20 | 10 | 5 | 6 | 1 |
| Q2 2021 | 12 | 13 | 5 | 11 | 2 |
| Q3 2021 | 5 | 8 | 11 | 9 | 6 |
| Q4 2021 | 7 | 8 | 7 | 10 | 4 |
| Q1 2022 | 3 | 15 | 5 | 2 | 11 |
| Q2 2022 | 25 | 0 | 1 | 35 | -35 |
| Q3 2022 | 3 | 4 | 3 | 8 | 3 |
| Q4 2022 | 5 | 3 | 5 | 3 | 7 |
| Q1 2023 | 3 | 3 | 3 | 3 | 2 |
Hedge funds changes in Regulus Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 8,000 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 5,000 | 4,000 |
| Q1 2019 | 0 | 5,000 |
| Q2 2019 | 7,000 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 6,000 | 0 |
| Q4 2020 | 92,000 | 34,000 |
| Q1 2021 | 702,000 | 134,000 |
| Q2 2021 | 376,000 | 343,000 |
| Q3 2021 | 373,000 | 216,000 |
| Q4 2021 | 70,000 | 1,000 |
| Q1 2022 | 195,000 | 0 |
| Q2 2022 | 1,282,000 | 0 |
| Q3 2022 | 1,138,000 | 0 |
| Q4 2022 | 955,776 | 1,781 |
| Q1 2023 | 237,737,000 | 0 |